Tower Research Capital (TRC)’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.82K | Sell |
204
-442
| -68% | -$4.4K | ﹤0.01% | 4594 |
|
|
2025
Q4 | $5.39K | Buy |
+646
| New | +$6.52K | ﹤0.01% | 4129 |
|
|
2025
Q3 | – | Sell |
-667
| Closed | -$5.66K | – | 5563 |
|
|
2025
Q2 | $5.66K | Buy |
667
+419
| +169% | +$4.27K | ﹤0.01% | 4162 |
|
|
2025
Q1 | $2.8K | Sell |
248
-525
| -68% | -$9.53K | ﹤0.01% | 4505 |
|
|
2024
Q4 | $15.8K | Buy |
773
+162
| +27% | +$4.73K | ﹤0.01% | 3383 |
|
|
2024
Q3 | $24.2K | Sell |
611
-986
| -62% | -$26.5K | ﹤0.01% | 3132 |
|
|
2024
Q2 | $28.1K | Buy |
1,597
+1,133
| +244% | +$19.2K | ﹤0.01% | 3537 |
|
|
2024
Q1 | $7.7K | Buy |
464
+195
| +72% | +$2.83K | ﹤0.01% | 4160 |
|
|
2023
Q4 | $5.08K | Buy |
+269
| New | +$5.05K | ﹤0.01% | 4884 |
|
|
2023
Q3 | – | Sell |
-1,028
| Closed | -$56.2K | – | 6182 |
|
|
2023
Q2 | $56.2K | Buy |
1,028
+544
| +112% | +$16.7K | ﹤0.01% | 2492 |
|
|
2023
Q1 | $9K | Sell |
484
-640
| -57% | -$11K | ﹤0.01% | 4534 |
|
|
2022
Q4 | $11K | Buy |
1,124
+352
| +46% | +$3.77K | ﹤0.01% | 3862 |
|
|
2022
Q3 | $10K | Buy |
772
+447
| +138% | +$6.77K | ﹤0.01% | 4568 |
|
|
2022
Q2 | $4K | Buy |
325
+272
| +513% | +$7.2K | ﹤0.01% | 5248 |
|
|
2022
Q1 | $3K | Buy |
+53
| New | +$2.25K | ﹤0.01% | 5407 |
|
|
2021
Q4 | – | Sell |
-68
| Closed | -$4K | – | 6507 |
|
|
2021
Q3 | $4K | Sell |
68
-238
| -78% | -$18.1K | ﹤0.01% | 4994 |
|
|
2021
Q2 | $31K | Sell |
306
-291
| -49% | -$30K | ﹤0.01% | 3460 |
|
|
2021
Q1 | $76K | Buy |
597
+317
| +113% | +$46.9K | ﹤0.01% | 2797 |
|
|
2020
Q4 | $31K | Sell |
280
-423
| -60% | -$47.4K | ﹤0.01% | 3546 |
|
|
2020
Q3 | $83K | Buy |
703
+573
| +441% | +$99.1K | ﹤0.01% | 3288 |
|
|
2020
Q2 | $28K | Buy |
+130
| New | +$30.7K | ﹤0.01% | 3492 |
|
|
2019
Q4 | – | Sell |
-22
| Closed | -$7K | – | 4245 |
|
|
2019
Q3 | $7K | Sell |
22
-17
| -44% | -$5.22K | ﹤0.01% | 3152 |
|
|
2019
Q2 | $13K | Buy |
+39
| New | +$19.8K | ﹤0.01% | 2421 |
|
|
2019
Q1 | – | Sell |
-162
| Closed | -$40K | – | 4202 |
|
|
2018
Q4 | $40K | Buy |
162
+148
| +1,057% | +$58.9K | ﹤0.01% | 1436 |
|
|
2018
Q3 | $7K | Buy |
+14
| New | +$6.78K | ﹤0.01% | 2969 |
|
|
2017
Q4 | – | Sell |
-4
| Closed | -$4K | – | 3934 |
|
|
2017
Q3 | $4K | Buy |
+4
| New | +$3.06K | ﹤0.01% | 3403 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | -$3K | – | 3782 |
|
|
2016
Q4 | $3K | Buy |
+4
| New | +$2.77K | ﹤0.01% | 3284 |
|
|
2016
Q3 | – | Sell |
-46
| Closed | -$39K | – | 4308 |
|
|
2016
Q2 | $39K | Buy |
46
+43
| +1,433% | +$40K | ﹤0.01% | 1731 |
|
|
2016
Q1 | $2K | Sell |
3
-21
| -88% | -$16.5K | ﹤0.01% | 3429 |
|
|
2015
Q4 | $28K | Sell |
24
-23
| -49% | -$26.8K | ﹤0.01% | 954 |
|
|
2015
Q3 | $40K | Buy |
47
+40
| +571% | +$58K | ﹤0.01% | 1180 |
|
|
2015
Q2 | $13K | Sell |
7
-17
| -71% | -$21.6K | ﹤0.01% | 2474 |
|
|
2015
Q1 | $29K | Buy |
+24
| New | +$28.1K | ﹤0.01% | 1938 |
|
|
2014
Q4 | – | Sell |
-10
| Closed | -$10K | – | 4588 |
|
|
2014
Q3 | $10K | Hold |
10
| – | – | ﹤0.01% | 2836 |
|
|
2014
Q2 | $12K | Buy |
10
+3
| +43% | +$3.61K | ﹤0.01% | 2219 |
|
|
2014
Q1 | $9K | Sell |
7
-34
| -83% | -$44.2K | ﹤0.01% | 2725 |
|
|
2013
Q4 | $48K | Sell |
41
-8
| -16% | -$11K | 0.01% | 1424 |
|
|
2013
Q3 | $61K | Buy |
+49
| New | +$33.3K | 0.01% | 1736 |
|
Other funds holding RMTI
VCM
VFT
WANY
Tower Research Capital (TRC)'s RMTI Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Rockwell Medical (RMTI) stake by 68% in Q1 2026, selling an estimated $4.4K and leaving 204 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #4594.
Tower Research Capital (TRC) first reported a position in RMTI in Q3 2013 and has held it in 38 quarters since. The position peaked at $83K in Q3 2020. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Tower Research Capital (TRC) held 204 shares of Rockwell Medical worth $1.82K as of Q1 2026.
- Tower Research Capital (TRC) sold 442 Rockwell Medical shares in Q1 2026, an estimated $4.4K.
- Rockwell Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4594 holding.
- Tower Research Capital (TRC) first reported a position in Rockwell Medical in Q3 2013 and has held it in 38 quarters since.
- Tower Research Capital (TRC)'s Rockwell Medical position peaked at $83K in Q3 2020.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.